Chart-Typ:
Zeitraum:
| Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn Wound Irrigation Solution | BOULDER, CO / ACCESS Newswire / June 30, 2026 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced it has received a new 510(k)... ► Artikel lesen |
| Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results | Revenues increased 48% in Q4 2026 compared to Q4 2025, and 37% in FY 2026 compared to FY 2025United States revenues increased 194% in Q4 2026 compared to Q4 2025 and 117% in FY 2026 compared to FY 2025Net... ► Artikel lesen |
| Sonoma Pharmaceuticals: 150.000 Aktien gekauft - das ist der Grund! | Die Aktie von Sonoma Pharmaceuticals ist Zockern aus der sharedeals.de-Community seit Jahren bekannt. Mehrfach wurden dreistellige Kurs-Peaks innerhalb kürzester Zeit für herausragend lukrative Trading-Exits... ► Artikel lesen |
| Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): Under Review | Original-Research: Jaguar Health Inc - from First Berlin Equity Research GmbH
17.07.2026 / 17:49 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer... ► Artikel lesen |
| Jaguar Health, Inc.: Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure | Company remains sharply focused on its ongoing global development program for crofelemer for rare IF diseasesNear-term milestones for IF program buttressed by continuing groundbreaking results of study... ► Artikel lesen |
| Jaguar Health, Inc.: Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend | Company remains sharply focused on its ongoing global development program for crofelemer for rare intestinal failure diseasesReminder: Two crofelemer presentations in pediatric intestinal failure patients... ► Artikel lesen |
| QXO, Inc. Completes Acquisition of TopBuild Corp. | Deal Expected to Be Substantially Accretive to QXO's Earnings
GREENWICH, Conn.--(BUSINESS WIRE)--QXO, Inc. (NYSE: QXO) today announced it has closed its previously disclosed acquisition of TopBuild... ► Artikel lesen |
| QXO, Inc. and TopBuild Corp. Stockholders Overwhelmingly Approve QXO's Acquisition of TopBuild | GREENWICH, Conn. & DAYTONA BEACH, Fla.--(BUSINESS WIRE)--QXO, Inc. (NYSE: QXO) ("QXO") and TopBuild Corp. (NYSE: BLD) ("TopBuild") today announced that stockholders of both companies overwhelmingly... ► Artikel lesen |
| Jacobs hat ganze Branchen aufgemischt: Ist QXO der nächste Coup? | Brad Jacobs hat mehrfach bewiesen, wie man in zersplitterten Märkten dominante Konzerne formt. Ist QXO der nächste Coup Den vollständigen Artikel lesen ... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NETCAPITAL INC finden Sie auf Wallstreet Online.